#metabolomics #lipidomics #neurology Abundance differences in circulating acylcarnitines, free fatty acids, phosphatidylcholines lysophosphatidylcholines 10 years prior to neuropathy assessment are associated with neuropathy status in type 2 diabetes. .
Lipids in blood predict nerve damage risk among patients with type 2 diabetes https://t.co/v5ZFXlHZ1T https://t.co/uQar8Nejlm https://t.co/FSa6uvPpyx
RT @pathologistmag: Which #Type2Diabetes patients are at greatest risk of #neuropathy? A retrospective cohort study identifies differences…
Which #Type2Diabetes patients are at greatest risk of #neuropathy? A retrospective cohort study identifies differences in #lipidomics profiles of patients who develop neuropathy within 10 years of initial profiling. https://t.co/SskTXmOEe6 #WorldDiabetesDa
One study at Michigan Medicine found that elevations of multiple lipid biomarkers in the serum are linked to the subsequent development of neuropathy in patients with type 2 diabetes. https://t.co/1GU4zCsRd3
RT @medical_xpress: Lipids in blood predict #nervedamage risk among patients with type 2 #diabetes @umich https://t.co/oZAwJ8gefo https://t…
Biomarqueurs lipidiques de la #neuropathie diabétique 10 ans avant le diagnostic : acides gras libres, acylcarnitines, lyso + phosphatidylcholines. Au fait, l'activité physique et l'hygiène de vie les régularisent😬10 ans avant ça peut le faire…#diabète ht
RT @medical_xpress: Lipids in blood predict #nervedamage risk among patients with type 2 #diabetes @umich https://t.co/oZAwJ8gefo https://t…
Lipids in blood predict #nervedamage risk among patients with type 2 #diabetes @umich https://t.co/oZAwJ8gefo https://t.co/t4CCTfJbYr
Serum lipidomic determinants of human diabetic neuropathy in type 2 diabetes #ACTN #MassSpec https://t.co/yHkDFN9paQ